Grady Memorial Hospital
6
2
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Pilot Trial for WounDx™ Clinical Decision Support Tool
Role: collaborator
A Communication Tool to Improve Communication in the ICU
Role: collaborator
Expansion of the T1DES Pilot to a Public Hospital
Role: collaborator
Near Patient Molecular Testing in Sepsis
Role: collaborator
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Role: collaborator
VENUS: Septic Gene Expression Using SeptiCyte
Role: collaborator
All 6 trials loaded